Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
The European Respiratory Journal
|
July 14, 2025
Neutrophils in pleural infection: untapped potential for targeted therapeutics
Amy Gilmour, James D Chalmers
European Respiratory Review : an Official Journal of the European Respiratory Society
|
June 18, 2025
Dipeptidyl peptidase-1 inhibitors in bronchiectasis
Emma Johnson, Amy Gilmour, James D Chalmers
Drugs
|
April 9, 2026
Targeting Inflammation in Bronchiectasis
Micheál Mac Aogáin, Amy Gilmour, James D Chalmers, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
August 15, 2019
The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner
Ying Zhang, Amy Gilmour, Young-Hoon Ahn, et al.
ERJ Open Research
|
June 18, 2024
A serum calprotectin lateral flow test as an inflammatory and prognostic marker in acute lung infection: a prospective observational study
Amy Gilmour, Chloe Hughes, Yan Hui Giam, et al.
Nature Communications
|
July 9, 2024
Neutrophil extracellular traps promote immunopathogenesis of virus-induced COPD exacerbations
Orestis Katsoulis, Marie Toussaint, Millie M Jackson, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 15, 2025
Endotypes of <i>Pseudomonas aeruginosa</i> Infection in Bronchiectasis Are Associated with Inhaled Antibiotic Response: Results from Two Randomized, Double-Blind, Placebo-controlled Phase III Trials (ORBIT 3 and ORBIT 4)
Rebecca C Hull, Jamie Stobo, Hani Abo-Leyah, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 16, 2024
A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Neutrophil-Mediated Killing of <i>Pseudomonas aeruginosa</i> in Patients with Bronchiectasis
Merete B Long, Amy Gilmour, Margaret Kehl, et al.
ERJ Open Research
|
March 12, 2024
SFX-01 in hospitalised patients with community-acquired pneumonia during the COVID-19 pandemic: a double-blind, randomised, placebo-controlled trial
Merete B Long, Hani Abo-Leyah, Yan Hui Giam, et al.
ERJ Open Research
|
March 11, 2026
Design and rationale of the AIR-NET trial: a randomised, open-label, multifactorial, multicentre, adaptive platform trial using a range of repurposed anti-inflammatory treatments to improve outcomes in patients with bronchiectasis within the EMBARC clinical research network
Merete B Long, Jaa Ming New, Jamie Stobo, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
The European Respiratory Journal
|
July 14, 2025
Neutrophils in pleural infection: untapped potential for targeted therapeutics
Amy Gilmour, James D Chalmers
European Respiratory Review : an Official Journal of the European Respiratory Society
|
June 18, 2025
Dipeptidyl peptidase-1 inhibitors in bronchiectasis
Emma Johnson, Amy Gilmour, James D Chalmers
Drugs
|
April 9, 2026
Targeting Inflammation in Bronchiectasis
Micheál Mac Aogáin, Amy Gilmour, James D Chalmers, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
August 15, 2019
The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner
Ying Zhang, Amy Gilmour, Young-Hoon Ahn, et al.
ERJ Open Research
|
June 18, 2024
A serum calprotectin lateral flow test as an inflammatory and prognostic marker in acute lung infection: a prospective observational study
Amy Gilmour, Chloe Hughes, Yan Hui Giam, et al.
Nature Communications
|
July 9, 2024
Neutrophil extracellular traps promote immunopathogenesis of virus-induced COPD exacerbations
Orestis Katsoulis, Marie Toussaint, Millie M Jackson, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 15, 2025
Endotypes of <i>Pseudomonas aeruginosa</i> Infection in Bronchiectasis Are Associated with Inhaled Antibiotic Response: Results from Two Randomized, Double-Blind, Placebo-controlled Phase III Trials (ORBIT 3 and ORBIT 4)
Rebecca C Hull, Jamie Stobo, Hani Abo-Leyah, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 16, 2024
A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Neutrophil-Mediated Killing of <i>Pseudomonas aeruginosa</i> in Patients with Bronchiectasis
Merete B Long, Amy Gilmour, Margaret Kehl, et al.
ERJ Open Research
|
March 12, 2024
SFX-01 in hospitalised patients with community-acquired pneumonia during the COVID-19 pandemic: a double-blind, randomised, placebo-controlled trial
Merete B Long, Hani Abo-Leyah, Yan Hui Giam, et al.
ERJ Open Research
|
March 11, 2026
Design and rationale of the AIR-NET trial: a randomised, open-label, multifactorial, multicentre, adaptive platform trial using a range of repurposed anti-inflammatory treatments to improve outcomes in patients with bronchiectasis within the EMBARC clinical research network
Merete B Long, Jaa Ming New, Jamie Stobo, et al.
Page
of 2